Orphan designation: Octreotide acetate Treatment of acromegaly, 05/08/2013 Withdrawn
Overview On 5 August 2013, orphan designation (EU/3/13/1170) was granted by the European Commission to Larode Ltd, United Kingdom, for octreotide acetate (oral use) for treatment of acromegaly. The sponsorship was transferred to FGK …